ENTRY       K05209                      KO
NAME        GRIN2A
DEFINITION  glutamate receptor ionotropic, NMDA 2A
PATHWAY     ko04014  Ras signaling pathway
            ko04015  Rap1 signaling pathway
            ko04020  Calcium signaling pathway
            ko04080  Neuroactive ligand-receptor interaction
            ko04713  Circadian entrainment
            ko04720  Long-term potentiation
            ko04724  Glutamatergic synapse
            ko04728  Dopaminergic synapse
            ko05010  Alzheimer's disease
            ko05014  Amyotrophic lateral sclerosis (ALS)
            ko05030  Cocaine addiction
            ko05031  Amphetamine addiction
            ko05033  Nicotine addiction
            ko05034  Alcoholism
            ko05322  Systemic lupus erythematosus
BRITE       KEGG Orthology (KO) [BR:ko00001]
             Environmental Information Processing
              Signal transduction
               04014 Ras signaling pathway
                K05209  GRIN2A; glutamate receptor ionotropic, NMDA 2A
               04015 Rap1 signaling pathway
                K05209  GRIN2A; glutamate receptor ionotropic, NMDA 2A
               04020 Calcium signaling pathway
                K05209  GRIN2A; glutamate receptor ionotropic, NMDA 2A
              Signaling molecules and interaction
               04080 Neuroactive ligand-receptor interaction
                K05209  GRIN2A; glutamate receptor ionotropic, NMDA 2A
             Organismal Systems
              Nervous system
               04724 Glutamatergic synapse
                K05209  GRIN2A; glutamate receptor ionotropic, NMDA 2A
               04728 Dopaminergic synapse
                K05209  GRIN2A; glutamate receptor ionotropic, NMDA 2A
               04720 Long-term potentiation
                K05209  GRIN2A; glutamate receptor ionotropic, NMDA 2A
              Environmental adaptation
               04713 Circadian entrainment
                K05209  GRIN2A; glutamate receptor ionotropic, NMDA 2A
             Human Diseases
              Immune diseases
               05322 Systemic lupus erythematosus
                K05209  GRIN2A; glutamate receptor ionotropic, NMDA 2A
              Neurodegenerative diseases
               05010 Alzheimer's disease
                K05209  GRIN2A; glutamate receptor ionotropic, NMDA 2A
               05014 Amyotrophic lateral sclerosis (ALS)
                K05209  GRIN2A; glutamate receptor ionotropic, NMDA 2A
              Substance dependence
               05030 Cocaine addiction
                K05209  GRIN2A; glutamate receptor ionotropic, NMDA 2A
               05031 Amphetamine addiction
                K05209  GRIN2A; glutamate receptor ionotropic, NMDA 2A
               05033 Nicotine addiction
                K05209  GRIN2A; glutamate receptor ionotropic, NMDA 2A
               05034 Alcoholism
                K05209  GRIN2A; glutamate receptor ionotropic, NMDA 2A
            Ion channels [BR:ko04040]
             Glutamate-gated cation channels
              Glutamate (ionotropic), NMDA
               K05209  GRIN2A; glutamate receptor ionotropic, NMDA 2A
DBLINKS     GO: 0004972 0005234
            TC: 1.A.10.1.6
GENES       HSA: 2903(GRIN2A)
            PTR: 454396(GRIN2A)
            PPS: 100977852(GRIN2A)
            GGO: 101124569(GRIN2A)
            PON: 100438553(GRIN2A)
            MCC: 100429880
            MCF: 102123126(GRIN2A)
            MMU: 14811(Grin2a)
            RNO: 24409(Grin2a)
            CGE: 100764315(Grin2a)
            HGL: 101716707
            TUP: 102487925(GRIN2A)
            CFA: 490012(GRIN2A)
            AML: 100469843
            FCA: 101086110(GRIN2A)
            PTG: 102969126(GRIN2A)
            BTA: 524212(GRIN2A)
            BOM: 102283831
            PHD: 102324750(GRIN2A)
            CHX: 102189537(GRIN2A)
            SSC: 100736832
            CFR: 102503788(GRIN2A)
            BACU: 103006151(GRIN2A)
            LVE: 103091670(GRIN2A)
            ECB: 100051329(GRIN2A)
            MYB: 102245838(GRIN2A)
            MYD: 102771313
            PALE: 102898336(GRIN2A)
            MDO: 100018255(GRIN2A)
            SHR: 100920008
            OAA: 100074436(GRIN2A)
            GGA: 427678(GRIN2A)
            TGU: 778440(GRIN2A)
            FAB: 101819385(GRIN2A)
            PHI: 102113741(GRIN2A)
            APLA: 101804769(GRIN2A)
            FPG: 101912351(GRIN2A)
            FCH: 102048497(GRIN2A)
            CLV: 102091639(GRIN2A)
            ASN: 102373605(GRIN2A)
            AMJ: 102565271
            PSS: 102459849(GRIN2A)
            CMY: 102936101(GRIN2A)
            ACS: 100557524
            PBI: 103060162
            XLA: 100127346(grin2a)
            XTR: 100489006(grin2a)
            DRE: 563297(grin2aa) 570493(grin2ab)
            TRU: 101061712 101069083
            MZE: 101467440 101485837
            OLA: 101161811 101164378
            XMA: 102226347 102237459
            LCM: 102359367
            CMK: 103186084(grin2a)
REFERENCE   PMID:11399431
  AUTHORS   Cull-Candy S, Brickley S, Farrant M
  TITLE     NMDA receptor subunits: diversity, development and disease.
  JOURNAL   Curr Opin Neurobiol 11:327-35 (2001)
REFERENCE   PMID:17088105
  AUTHORS   Paoletti P, Neyton J
  TITLE     NMDA receptor subunits: function and pharmacology.
  JOURNAL   Curr Opin Pharmacol 7:39-47 (2007)
///
